Royalty Report: Medical, Device, Surgical – Collection: 5568


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 9


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 9

Primary Industries

  • Medical
  • Device
  • Surgical
  • cardiac
  • Ophthalmological
  • Therapeutic
  • Cancer
  • Laser

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 5568

License Grant
The licensee obtained an exclusive licensing for cardiovascular uses of proprietary argon gas based technology – a cryoablation system designed to treat cardiac arrhythmias.
License Property
Cryoablation is a process that uses cold energy (cryo) to kill tissue (ablation).

Cryoablation is used in a variety of clinical applications using hollow needles (cryoprobes) through which cooled (from a peripheral freezing unit), thermally conductive, gases and fluids are circulated. Cryoprobes are inserted into or placed adjacent to tissue which is determined to be diseased in such a way that ablation will provide correction yielding benefit to the patient. When the probes are in place, the cryogenic freezing unit removes heat ('cools') from the tip of the probe and by extension from the surrounding tissues.

IPSCIO Record ID: 163887

License Grant
Assignor sells, assigns, conveys, transfers and delivers to Assignee, its successors and permitted assigns, the Spot Catheter Patents and the Spot Catheter Technology and the Linear Catheter Patents and the Linear Catheter Technology to be used only in the Field of Use.
License Property
Assignor is in the business of developing implantable cardiac defibrillators and electrophysiology catheters. The IP includes patents and U.S. Patent Applications, Serial Nos. 08/496,947 and 09/073,651 and corresponding foreign patents.
Field of Use
The Field of Use shall mean the radio frequency (RF) cardiac ablation therapy field.  This agreement pertains to the medical industry.

IPSCIO Record ID: 118680

License Grant
Licensor granted us a non-exclusive license to its patent covering excimer laser ablation of tissue.  The terms of the license permit us to sublicense our subsidiaries.
License Property
The excimer laser systems and related products are used to perform procedures that correct common refractive vision disorders such as nearsightedness, farsightedness and astigmatism.
Field of Use
Laser vision correction is a surgical procedure for correcting disorders such as nearsightedness, farsightedness and astigmatism using an excimer laser. This procedure uses ultraviolet laser energy to remove tissue from the surface of, and thus sculpt, the cornea into a predetermined shape. Because the excimer laser is a cold laser, it is possible to ablate, or remove precise amounts of corneal tissue without causing thermal damage to surrounding tissue. The goal of laser vision correction is to eliminate or reduce a persons reliance on corrective eyewear.

IPSCIO Record ID: 291408

License Grant
For Updates and Information, Licensor grants a non-exclusive research license under the Licensor Intellectual Property and Licensor Console Program Intellectual Property solely to the extent necessary for Licensee to perform its activities under the Program.

For the first option, Licensor and third party grant a non-exclusive, worldwide license, under the Licensor Console Program Intellectual Property required to use, manufacture, have manufactured, market, offer for sale, sale, import or export Licensor Consoles, solely for using, manufacturing, marketing, offering for sale, selling, importing and exporting Licensor Consoles for use with non-expandable member catheter-based cryotherapy devices developed by Licensee, either on a stand-alone basis or as part of Bundled Products.

License Property
Licensor Console means an automated console generator developed by Licensee pursuant to the Program which delivers N20 to the Licensor Cryo Balloon at greater than 750 psi and up to 900 psi, as improved or modified by any party in the course of the Program or by Licensor, third party or any of their Affiliates during the term of this Agreement.

Cryo Balloon means Licensors cryo-therapy balloon.

Cryo Console means Licensees automated console generator developed pursuant to the Program to deliver N2O to the third party Cryo Balloon at or below 750psi, including any modifications or improvements made thereto by any party in the course of the Program or by third party, Licensor or any of their Affiliates pursuant to any license granted under this Agreement. Cryo Console does not include any Licensees console that cannot be used with third party Cryo Balloons or any upgraded console developed by Licensee after the Program has been completed.

Bundled Product means a Product and other products that are not Products either packaged together for sale or shipment as a single unit or sold together in a kit, where the purchaser is charged a single individual purchase price for such combination of products.

Field of Use
The Field means therapeutic cryo-balloon systems for the treatment of cardiac arrhythmias.

Cryoablation balloon catheter is a form of catheter ablation which uses cryo, or freezing, energy rather than heat to precisely disable heart tissue that causes irregular heartbeats.

IPSCIO Record ID: 245918

License Grant
License Grant to Licensee under the Licensor Infusion Claims. Subject to the terms and conditions of this Agreement, including, without limitation, the limitations set forth in this agreement, and in consideration of the payment of royalties by Licensee to Licensor, Licensor hereby grants to Licensee and Licensee’s Affiliates, under the Licensor Infusion Claims, a non-exclusive license throughout the Licensed Territories in the Field to make, have made, use, practice, import, offer to sell, sell and otherwise dispose of or make available for use, directly or indirectly, Products and Methods which, but for the license granted herein, would infringe any one or more of the Licensor Infusion Claims. Notwithstanding any other provision of this Agreement
(a) the foregoing license extends only to such Products and Methods as are offered for sale, sold and otherwise disposed of or made available for use under Licensee’s (or its Affiliates’) own trademarks, tradenames and/or label(s), which shall be the most prominent trademarks, tradenames and/or label(s) thereon, and does not extend, and shall not be construed to extend, to any Products, or parts or components thereof, offered for sale, sold or otherwise disposed of or made available for use to any Third Person by Licensee or its Affiliates for resale or re-distribution by such Third Person solely under such Third Person’s own trademarks, tradenames and/or label(s); and
(b) Licensee, on behalf of itself and its Affiliates, hereby covenants and agrees not to market, offer for sale or sell any Products or Methods that, absent the foregoing license, would infringe the Licensor Infusion Claims, until eighteen (18) months after the Effective Date.
License Property
Licensor Infusion Claims shall mean those Claims of any patents within the Licensor Patent Portfolio which require for infringement liquid infusion capability or the use of liquid infusion.

Licensor Patent Portfolio
U.S. Patent No. 5,458,597 – Device for treating cancer and non-malignant tumors and methods
U.S. Patent No. 5,472,441 – Device for treating cancer and non-malignant tumors and methods
U.S. Patent No. 5,486,161 – Medical probe device and method

Field of Use
Field shall mean Products and Methods used to ablate tumors with radio frequency (RF) electrical energy.  Sub-Field shall mean tumor ablation within the Field directed to specific organs or regions of the body.

IPSCIO Record ID: 158782

License Grant
Pursuant to a prior employment agreement, the Licensor, of Japan and residing in the U.S. and the Licensee have a contractual agreement for patents.
License Property
The patents are for Contact Laser(TM) Probes and Scalpels and Contact Fibers, Heraeus LaserBlade(TM) Scalpels and Contact Fibers, HSI conical contact fibers.

'Contact Laser(TM) Patents' means the following three U.S. Patent Nos. 4,693,244; 4,592,353; and 4,736,743.

Field of Use
Licensee's Contact Laser(TM) System, unlike conventional laser systems, enables the surgeon to use the laser instrument in direct contact with the tissue being treated, thereby significantly enhancing the ease of use and precision of laser surgery in many applications.

IPSCIO Record ID: 1814

License Grant
The Company secured the exclusive worldwide right to the laser-based Photon machine from the Licensor, an individual.
License Property
The Photon (trademark) LaserPhaco (trademark) system is protected under a United States patent issued in 1987 (U.S. Patent Number 4,694,828) for the utility and methods of laser ablation, aspiration and irrigation of tissue through a hand-held probe of a unique design.
Field of Use
The rights granted apply to cataracts of the eye; ophthalmic cataract surgery equipment.

IPSCIO Record ID: 240566

License Grant
Licensor, an individual, hereby grants to Licensee a sole and exclusive, worldwide license under the Patent Rights to make, use, offer for sale and sell the Licensed Products in the Field of Use. Licensee shall have the right to sub-license its rights hereunder to no more than one sub-licensee in each country in the world (reserving no rights to itself in the territory of any such sub-license) on prior written notice (which shall include the name of the sub-licensee and the territorial scope of its sub-license) to Licensor. Each such sub-license shall be subject and subordinate to the terms and conditions of this Agreement, except that no sub-licensee shall have the right to grant further sub-licenses.
License Property
Patent Rights shall mean U.S. Patent Nos. 5,549,632 and 5,984,916
5,549,632 – Method and apparatus for ophthalmic surgery
5,984,916 – Ophthalmic surgical laser and method
Field of Use
Field of Use shall mean use for ophthalmic surgery.

IPSCIO Record ID: 29254

License Grant
The Licensor granted the Licensee an exclusive license (including the right to grant sublicenses) in and to the devices and the technology for the purposes of making, having made, using and selling the Devices.
License Property
The devices relate to ophthalmic applications of fluid jet technology.
Field of Use
Licensed Field of Use means the medical and surgical fields related to ophthalmological applications.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.